Skip to main content


Bladder Cancer

Featured

Guideline Updates
NCCN updated its clinical practice guideline for bladder cancer, removing atezolizumab as an alternative second-line systemic therapy option for locally advanced or metastatic…
Videos
Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-…
Guideline Updates
NCCN released an update to its clinical practice guideline for bladder cancer.
Videos
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition…
Videos
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors…
Back to Top